logo
[breadcrumb_custom]

Tag: PRQR Stock
Finance

ProQR Therapeutics N.V (PRQR) Stock: A Comprehensive 52-Week Review

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. ProQR Therapeutics N.V’s current trading price is -39.48% away from its 52-week high, while its distance from the 52-week low is 109.91%. The stock’s price range over this period has fluctuated between $1.11 and $3.85. The company, operating within the financial sector, had a trading volume of approximately 0.58 million for the day, which was noticeably higher than the average daily share volume of 0.31 million over the last 3 months. In terms of market performance, ProQR
Equity News

How Did The ProQR Therapeutics (PRQR) Stock Rise 35% Pre-Hours?

After the company announced an expansion of cooperation, shares of ProQR Therapeutics N.V. (Nasdaq: PRQR) were up 35.15% at $2.23 at the time of our last check in pre-market trading. What partnership will PRQR be extending? Eli Lilly and Company (NYSE: LLY) and ProQR Therapeutics (PRQR) have expanded their license and partnership arrangement to concentrate more on the research and marketing of novel genetic treatments. The partnership, which was first disclosed in September 2021, used ProQR Therapeutics’ exclusive Axiomer RNA editing tool to treat liver and nervous system diseases. Since the beginning of the project, platform improvements have greatly improved

Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.
Facebook-f Twitter Google-plus-g Pinterest

Quick Links

Categories

©Fueled By Smart TechOne